Wed, January 31, 2024
Tue, January 30, 2024
Mon, January 29, 2024
Fri, January 26, 2024
Thu, January 25, 2024

Raghuram Selvaraju Maintained (BBIO) at Strong Buy with Increased Target to $47 on, Jan 29th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-47-on-jan-29th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Increased Target from $22 to $47 on, Jan 29th, 2024.

Raghuram has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $50 on, Monday, January 22nd, 2024
  • David Lebowitz of "Citigroup" Initiated at Strong Buy and Held Target at $42 on, Tuesday, November 7th, 2023

Publication Contributing Sources